BACK TO TOP
KSE100
169,401.31
-1045.98
(-0.61%)
KSE100PR
53,217.58
-328.59
(-0.61%)
ALLSHR
102,616.14
-366.74
(-0.36%)
KSE30
51,493.75
-337.88
(-0.65%)
KMI30
241,630.76
-2482.84
(-1.02%)
BKTI
46,166.07
89.34
(0.19%)
OGTI
33,637.49
-324.86
(-0.96%)
KMIALLSHR
66,663.14
-513.48
(-0.76%)
PSXDIV20
74,174.27
-266.44
(-0.36%)
UPP9
57,900.60
-505.63
(-0.87%)
NITPGI
43,431.18
-375.33
(-0.86%)
NBPPGI
47,649.66
-418.16
(-0.87%)
MZNPI
29,814.45
-307.91
(-1.02%)
JSMFI
45,801.80
39.51
(0.09%)
ACI
25,008.49
-185.46
(-0.74%)
JSGBKTI
68,745.94
554.07
(0.81%)
HBLTTI
17,755.65
15-12-2025
5.34
(0.03%)
MII30
22,083.33
-226.89
(-1.02%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.88.90
-0.43
(-0.48%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Wed, Dec 17, 2025 11:19 AM
REG
DFC
CSF
ODL
Open
89.33
High
89.99
Low
88.75
Volume
243,493
CIRCUIT BREAKER
80.40 — 98.26
DAY RANGE
88.75 — 89.99
52-WEEK RANGE ^
60.50 — 109.30
Ask Price
88.90
Ask Volume
1,300
Bid Price
88.89
Bid Volume
277
LDCP
89.33
VAR
13.00
HAIRCUT
17.50
P/E Ratio (TTM) **
22.74
1-Year Change * ^
26.39%
YTD Change * ^
30.52%
Last update: Wed, Dec 17, 2025 11:19 AM
Open
89.00
High
89.73
Low
89.00
Close
89.25
Change
-0.38%
LDCP
89.59
Volume
19,500
Total Trades
24
CIRCUIT BREAKER
80.63 — 98.55
DAY RANGE
89.00 — 89.73
Ask Price
89.25
Ask Volume
49,500
Bid Price
88.59
Bid Volume
2,000
Last update: Sun, Nov 30, 2025 6:07 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
89.71
Volume
0
Total Trades
0
CIRCUIT BREAKER
80.74 — 98.68
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Nov 30, 2025 6:07 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
92.07
Volume
0
Total Trades
0
CIRCUIT BREAKER
82.86 — 101.28
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Nov 30, 2025 6:07 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
91.02
Volume
0
Total Trades
0
CIRCUIT BREAKER
81.92 — 100.12
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.

KEY PEOPLE
Rizwan AhmadCEO
Nadeem AmjadChairperson
Ghulam DastgeerCompany Secretary
ADDRESS

3-KM, Head Balloki Road, Bhai Pheru, Distt Kasur

WEBSITE

www.citipharma.com.pk

REGISTRAR

F.D Registrar Services (Pvt.) Ltd.

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
20,310,200.68
Shares
228,461,200
Free Float
114,230,600
Free Float
50.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 30, 2025TRANSMISSION OF QUARTERLY REPORT FOR THE PERIOD ENDED View   PDF
Oct 29, 2025Financial Results for the Quarter Ended View   PDF
Oct 7, 2025Transmission of Annual Report for the Year Ended View   PDF
Oct 2, 2025Financial Results for the year ended View   PDF
May 2, 2025Transmission of financial statements for the Nine Months period ended 31 March 2025 View   PDF
DateTitleDocument
Nov 13, 2025Certified True Copy of the Resolutions Passed in the Annual General Meeting View   PDF
Oct 29, 2025Board Meeting Other Than Financial Results (Post Election BOD Meeting) View   
Oct 24, 2025Board Meeting View   
Oct 6, 2025Notice of Annual General Meeting View   PDF
Sep 25, 2025Board Meeting View   
DateTitleDocument
Nov 6, 2025Credit of Final Cash Dividend (2025) View   PDF
Oct 20, 2025Notice of Election of Directors u/s 159(4) of the Companies Act, 2017 View   PDF
Oct 16, 2025CLARIFICATION REGARDING NEWS CIRCULATING ON SOCIAL MEDIA PLATFORMS View   PDF
Sep 12, 2025Material Information View   PDF
Aug 6, 2025Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations
REVOKED
View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales13,153,52112,409,23912,396,9839,779,880
Profit after Taxation892,039833,464657,984635,884
EPS3.903.652.882.88
Q1 2026Q3 2025Q2 2025Q1 2025
Sales3,370,2473,341,1083,534,4323,224,645
Profit after Taxation203,691220,375256,979201,497
EPS0.890.961.120.88
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)15.3412.7812.1613.83
Net Profit Margin (%)6.786.725.316.50
EPS Growth (%)6.8526.74(20.88)
PEG3.140.29(0.54)

Payouts

Financial Reports